Formac is a drug delivery company focused on the formulation of poorly soluble active pharmaceutical ingredients. Using its unique mesoporous silica materials, Formac has created an innovative formulation platform to overcome solubility-limited bioavailability. Formac’s technology is easily implementable and upscalable in established manufacturing units and provides solid dosage forms with excellent physical and chemical stability.

17 June 2013 — Formac receives final advice letter from the European Medicines Agency

7 new chemical entities are currently undergoing preclinical assessment using Formac's technology.

Active compounds that emerge from contemporary drug discovery pipelines are becoming increasingly water-insoluble and therefore highly complex to formulate. Formac provides the pharmaceutical industry with an innovative, powerful and cost-effective formulation platform to tackle this solubility problem.